Chittorgarh.com Logo
Loading...

Windlas Biotech Limited IPO (Windlas Biotech IPO) Detail

Aug 4, 2021 - Aug 6, 2021

Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

It further sells its own branded products in the trade generics and OTC markets. Currently, the focus of the company is to launch complex generic products in the chronic therapeutic category related to lifestyle-related disorders. The business operates in 3 verticals; 1. CDMO Products and services, 2. Domestic trade generics and Over-the-counter (OTC) market (nutraceutical and health supplement products), and 3. Export.

Leading pharma companies i.e. Pfizer Ltd, Sanofi India Ltd, Cadila Healthcare Ltd, Emcure Pharmaceuticals Ltd, Eris Lifesciences Ltd, Intas Pharmaceuticals Ltd, and Systopic Laboratories Private Limited are some of the marquee customers of Windlas Biotech. Its manufacturing facilities are located at Dehradun with an installed operating capacity of 7,063.83 million tablets/ capsules, 54.46 million pouch/ sachet, and 61.08 million liquid bottles.

Competitive strengths

  • Leading market player in the domestic pharmaceutical formulation CDMO segment.
  • Strong focus on the chronic therapeutic category.
  • state-of-the-art manufacturing facilities in Dehradun, Uttarakhand.
  • Professional and experienced Promoters and a senior management team.
  • An innovative product portfolio of complex generic products.
  • Robust financial performance track record.

Company Financials

Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (β‚Ή in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2,961.23 3,384.88 2,981.80
Total Revenue 4,306.95 3,313.39 3,115.25
Profit After Tax 155.70 162.13 638.22

Objects of the Issue

  • To purchase equipment required for capacity expansion of our existing facility at Dehradun Plant IV.
  • To finance incremental working capital requirements of the company.
  • Repayment/prepayment of company's borrowings.
  • General corporate purposes.

Windlas Biotech IPO Details

Windlas Biotech IPO Date Aug 4, 2021 to Aug 6, 2021
Windlas Biotech IPO Face Value ₹5 per share
Windlas Biotech IPO Price ₹448 to ₹460 per share
Windlas Biotech IPO Lot Size 30 Shares
Issue Size[.] shares of ₹5
(aggregating up to ₹401.54 Cr)
Fresh Issue[.] shares of ₹5
(aggregating up to ₹165.00 Cr)
Offer for Sale5,142,067 shares of ₹5
(aggregating up to ₹236.54 Cr)
Issue Type Book Built Issue IPO
Listing At BSE, NSE
Company Promoters

Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and AKW WBL Family Pvt Trust are the company promoters.

Windlas Biotech IPO Timeline (Tentative Timetable)

Windlas Biotech IPO opens on Aug 4, 2021, and closes on Aug 6, 2021. The Windlas Biotech IPO bid date is from Aug 4, 2021 10.00 A.M. to Aug 6, 2021 5.00 P.M. The Cut-off time for UPI Mandate confirmation is 12 P.M. on the next day of issue closing day.

Event Date
Windlas Biotech IPO Opening Date Aug 4, 2021
Windlas Biotech IPO Closing Date Aug 6, 2021
Basis of Allotment Aug 11, 2021
Initiation of Refunds Aug 12, 2021
Credit of Shares to Demat Aug 13, 2021
Windlas Biotech IPO Listing Date Aug 17, 2021

Windlas Biotech IPO Lot Size

The Windlas Biotech IPO lot size is 30 shares. A retail-individual investor can apply for up to 14 lots (420 shares or ₹193,200).

Application Lots Shares Amount
Minimum 1 30 ₹13,800
Maximum 14 420 ₹193,200

Windlas Biotech IPO Promoter Holding

Pre Issue Share Holding 78%
Post Issue Share Holding 65.16%

Windlas Biotech IPO Review

Despite growth in its top lines, WBL has posted declining trends for bottom lines in order to clear its slate. Based on its financial parameters, the issue is aggressively priced. All recent moves will take about two years to be on a fast forward mode. Thus it is purely a long term bet at the current valuations that discounts all near term positives. Cash surplus investors may consider it with a long term perspective. Read detail review...


Windlas Biotech IPO Subscription Status (Bidding Detail)

The Windlas Biotech IPO is subscribed 22.44 times on Aug 6, 2021 6:50:00 PM. The public issue subscribed 24.22 times in the retail category, 24.40 times in the QIB category, and 15.73 times in the NII category. Check Day by Day Subscription Details (Live Status)

Application Wise IPO Subscription (Retail): 20.63 times

CategorySubscription (times)
QIB24.40
NII15.73
Retail24.22
Total22.44

Windlas Biotech IPO Prospectus

Windlas Biotech IPO Rating

935
4.0
Rating:Rated 4.0 stars
Vote Here ...

Windlas Biotech IPO Listing Date

Listing Date Monday, August 16, 2021
BSE Script Code 543329
NSE Symbol WINDLAS
Listing In
ISIN INE0H5O01029
IPO Price ₹460 per share
Face Value ₹5 per share

Listing Day Trading Information

.
IPO Price
Open
Low
High
Last Trade
BSE
₹460.00
₹439.00
₹405.00
₹452.10
₹406.70
NSE
₹460.00
₹437.00
₹405.00
₹452.00
₹407.15

Company Contact Information

Windlas Biotech Limited
40/1, Mohabewala Industrial Area,
Dehradun, 248110

Phone: +91 135 6608000
Email: grievance@windlasbiotech.com
Website: http://www.windlasbiotech.com/

Windlas Biotech IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270
Email: windlas.ipo@linkintime.co.in
Website: https://linkintime.co.in/

Windlas Biotech IPO FAQs

Windlas Biotech IPO is a main-board IPO of [.] equity shares of the face value of ₹5 aggregating up to ₹401.54 Crores. The issue is priced at ₹448 to ₹460 per share. The minimum order quantity is 30 Shares.

The IPO opens on Aug 4, 2021, and closes on Aug 6, 2021.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Zerodha customers can apply online in Windlas Biotech IPO using UPI as a payment gateway. Zerodha customers can apply in Windlas Biotech IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Windlas Biotech IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Windlas Biotech IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. ‘Submit’ IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Windlas Biotech IPO opens on Aug 4, 2021 and closes on Aug 6, 2021.

Windlas Biotech IPO lot size is 30 Shares and the minimum order quantity is .

You can apply in Windlas Biotech IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Windlas Biotech IPO will be done on Aug 11, 2021, and the allotted shares will be credited to your demat account by Aug 13, 2021. Check the Windlas Biotech IPO allotment status.

The Windlas Biotech IPO listing date is on Monday, August 16, 2021.
Open an Instant Account with Zerodha

Windlas Biotech IPO Message Board

Ranked Members of Chittorgarh.com Forum  Ranked Members | Most Liked Members

Loading...

449 Comments

247. mvsmr |   Link |Sep 20, 2021 12:32:34 PM
Windlas never touched the IPO price, should I sell the allotted lot for loss or any hope to get some gains in future?
246. Samruddhi Pai |   Link |Sep 1, 2021 11:25:02 AM
WINDLAS IS FRAUD. I HAVEN''T GOT BACK MY IPO REFUND YET. SHAME ON THE COMPANY
BLOODY THIEVES
245. Samruddhi Pai |   Link |Aug 30, 2021 6:30:09 PM
I HAD SUBSCRIBED FOR THE IPO OF WINDLAS BIOTECH. I HAVE NOT RECIEVED RS 13500 YET. THE MANDATE DATE WAS 24TH AUGUST AND WHEN I CHECKED WITH THE BANK THEY DON''T HAVE ANY BLOCKED OR LIEN AMOUNT. IS THIS COMPANY A FRAUD? WHEN WILL i GET MY MONEY?
244. MS ASSOCIATE |   Link |Aug 27, 2021 6:18:14 PM
Aptus Value share price close above issue price
244.1. mvsmr |   Link |Sep 6, 2021 5:18:06 PM
@MS Associate, have you sold your shares or still holding them?
243. Nagur |   Link |Aug 25, 2021 12:30:08 PM
Hai sir,
My name is shaik Nagur meera i still cant get ipo refund amount pls check for me
Client id : 20452722
DP id : INE301774
242. Cyberdude |   Link |Aug 23, 2021 11:52:05 AM
how much more will this go down? this is a profit-making company and in the niche domain still, prices are going down. why?
The same is happening with Glenmark life science as well. both of them are giving loss right now :(.
241. Justaninvestor |   Link |Aug 20, 2021 11:39:39 PM
Is it good around 300.
240. Ramsan |   Link |Aug 20, 2021 5:32:30 PM
Hi anybody else yet to get refund!?
tomoro is mandate expiry Can we expect tomoro
Or else what to do
Please guide
240.7. Unknown soul |   Link |Aug 23, 2021 4:44:34 PM
Okay pls let me know once you got the amount
240.8. Ramsan |   Link |Aug 24, 2021 1:44:51 PM
Finally got it
239. RajK |   Link |Aug 20, 2021 8:24:21 AM
Let me Hold this? Or sell. Guide me. 2500 loss in this script.
238. Subbiah Ramanathan |   Link |Aug 16, 2021 1:54:15 PM
eagle eye said premium is 80+5., what happened? she failed in sona comstar also. but u people say she only quoted GMP. . shwe should not post such GMP,, NEW INVESTORS ARE LOOSING MONEY, BEC SHE HAS QUOTED GMP
238.9. dhruvc |   Link |Aug 19, 2021 8:56:25 AM
GMP before listing does not guarantee gains on listing - GMP changes everyday. I do not see any fault of the person who posted the GMP. Investors investing in the IPO should not blindly apply on GMP, but look on the long term prospects of the stock as well. In this IPO rally, even kachra stocks like chemplast had GMP irrespective of such high valuations.

And irrespective of sound valuations, bright future and good GMP, risk is always there and listing gains would not be 100% guaranteed. Hence, only use your surplus cash.
238.10. DuckkyDuck |   Link |Aug 20, 2021 1:20:16 AM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
This is all new members mistake. All these new people coming to market without any knowledge. They just listen from here and there, and buy based on GMP. They just zomato is giving 80% return and jump in stock market. They dont do any research. They dont know the "downs" of market bcoz they have never seen that in these short period of time. But we are here from long, and know what market can do.
GMP posting and listing is not related. Also she just posted the GMP, not recommended you to buy. If she didn''t recommended you to buy, why u bought??? If others dont have knowledge and you have so much knowledge you shouldn''t have bought right? And in worst case if someone recommended you to buy something, you have the ultimate decision. You are responsible for your losses, not anyone else.
Its like any Ad on tv. There are ADs of lots of cooking oil or may be lots of cars. But they are just Ads. You have to decide whether u want car, which car is best suited for you, what you want in it, what price etc.
237. Mr.Yash.Raghuvanshi |   Link |Aug 16, 2021 12:20:43 PM
Can anyone tell me what to do with Windlas hold until Q1 Results or sell at loss ?
I have 2 lot. Pls suggest something I''m new
237.3. Srinijinx |   Link |Aug 18, 2021 1:36:50 PM
Please book loss. We can enter later
237.4. Srinijinx |   Link |Aug 19, 2021 9:19:08 PM
Exit
236. Roopa shree p |   Link |Aug 13, 2021 10:49:35 AM
I''m not refunded my blocked amount any one tell me when it''s refunded
236.3. Ramsan |   Link |Aug 19, 2021 8:48:21 AM
@unknown no 😭
236.4. Unknown soul |   Link |Aug 22, 2021 12:56:04 PM
Did you got refund?
235. gundu anna |   Link |Aug 17, 2021 2:28:37 PM
IPO Mentor IPO Mentor (500+ Posts, 100+ Likes)
When excessive retail punting and on first day get oversubscribed several times, these type of issue must come to market to weed out the speculators.
234. rsk |   Link |Aug 16, 2021 9:29:27 PM
Top Contributor Top Contributor (400+ Posts, 200+ Likes)
16-Aug-21      WINDLAS      Windlas Biotech Limited      ICICI LTD TRADING A/C      SELL      122350      417.62      -
233. Kailash sharma |   Link |Aug 16, 2021 9:19:05 PM
Applying in IPO if profitable then like senior mambers if loss then abuset them it''s totally wrong if you are investing or trading in share market only 5 to 10% loss is not a big one.
232. Ipolobo |   Link |Aug 16, 2021 6:06:58 PM
Have one lot, is it advisable to buy more to average down ?
232.1. Mr. Singh |   Link |Aug 16, 2021 7:50:57 PM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
No
231. Regulagedda Ambica Prasad |   Link |Aug 16, 2021 7:05:07 PM
Top Contributor Top Contributor (300+ Posts, 200+ Likes)
Started bottom fishing at 405
230. JUSTVIKRANT |   Link |Aug 16, 2021 6:44:10 PM
Well said . + - banta hai, sirf uper jana thik nahi.
229. Cautious ipo |   Link |Aug 6, 2021 11:59:13 AM
IPO Guru IPO Guru (1500+ Posts, 900+ Likes)
Listing below 400 ???
229.2. Rahul Popat |   Link |Aug 7, 2021 9:21:33 AM
Top Contributor Top Contributor (200+ Posts, 400+ Likes)
In dreams
229.3. Cautious ipo |   Link |Aug 16, 2021 6:43:28 PM
IPO Guru IPO Guru (1500+ Posts, 900+ Likes)
Test 405 atleast
228. arunARUN |   Link |Aug 16, 2021 4:42:50 PM
IPO Guru IPO Guru (1200+ Posts, 1100+ Likes)
Salute to all who give out GMP at personal risk of reputation. Sad part is that participants dont understand that grey market lacks depth and is expected to be more volatile. Grey saudas are useful for those who sell kostak or subject to (non greedy- earning for lending name without taking risk)
There are poor comments specially by new members whose understanding of market is very poor. All i can say is that god give them some gyan by making them lose some money
228.1. Spock πŸ–– |   Link |Aug 16, 2021 5:28:35 PM
IPO Mentor IPO Mentor (700+ Posts, 800+ Likes)
60% who posts GMP here are referring GMP from other 30% member''s post and writing here with +-5-10.
This 60% don''t even deal in GMP, they just want to increase comments count to achieve forum tags.